LAHORE - The Dilawar Hussain Foundation and Novo Nordisk have signed a Product Donation Agreement for the betterment of healthcare in Pakistan. The agreement was signed between Mr. Yasir Altaf (CPO of Dilawar Hussain Foundation) and Dr. Safwan Sayed (Director MRQ of Novo Nordisk Pharma). Novo Nordisk has also donated 1,000 insulin vials for the deserving diabetes patients, which will be distributed free of cost among the patients who are in need and cannot afford the insulin. We hope that these collaborative efforts prove to be fruitful for the healthcare system in Pakistan.